Cargando…
Erratum to “Cardiac Damage Staging Classification in Asymptomatic Moderate or Severe Primary Mitral Regurgitation”: [Structural Heart 2022;6(1):100004]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236776/ https://www.ncbi.nlm.nih.gov/pubmed/37275587 http://dx.doi.org/10.1016/j.shj.2023.100157 |
Ejemplares similares
-
Cardiac Damage Staging Classification in Asymptomatic Moderate or Severe Primary Mitral Regurgitation
por: Bernard, Jérémy, et al.
Publicado: (2022) -
Erratum: Surgical Timing of Degenerative Mitral Regurgitation: What to Consider
Publicado: (2013) -
Menghrajani K, Gomez-Arteaga A, Madero-Marroquin R, et al. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Adv. 2022;6(3):828-847.
Publicado: (2023) -
Tam CS, Dimopoulos M, Garcia-Sanz R, et al. Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies. Blood Adv. 2022;6(4):1296-1308.
Publicado: (2022) -
Fabrizio VA, Boelens JJ, Mauguen A, et al. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood Adv. 2022;6(7):1961-1968.
Publicado: (2023)